Epidural Anesthesia With Chloroprocaine Versus Lidocaine
Information source: Jinling Hospital, China
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Anesthesia
Intervention: Chloroprocaine (Drug); Lidocaine (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Jinling Hospital, China Official(s) and/or principal investigator(s): Weiyan Li, M.D., Study Director, Affiliation: School of Medicine, Nanjing University
Summary
Chinese made chloroprocaine has a rapid onset time, effective methodology, can last for a
short time, provides fast motor recovery and causes no significant side effects.
Clinical Details
Official title: Low Epidural Anesthesia With Chloroprocaine Versus Lidocaine: a Prospective, Randomized, Double-blinded Multi-centre Clinical Trial in China
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)
Primary outcome: Epidural anesthesia effects of chloroprocaine versus lidocaine
Secondary outcome: Comparison of vital signs between chloroprocaine and lidocaine groups
Detailed description:
Chloroprocaine hydrochloride is the chloridized local anesthetic of procaine hydrochloride,
with twice the anesthetic intensity, four to five times the metabolization and half the side
effect of procaine. The chloroprocaine hydrochloride product made in China has been on sale
since 2002. To determine the clinical efficacy of low-epidural anesthesia with
chloroprocaine versus lidocaine, the investigators carried out a prospective, randomized,
double-blinded multi-centre clinical trial. The results demonstrate that epidural anesthesia
using chloroprocaine has a more rapid onset time and shorter duration than with lidocaine.
It can also provide a reliable sensory and motor block in epidural anesthesia, and is thus a
more attractive alternative than lidocaine for middle and short duration surgical
procedures.
Eligibility
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Weight no more than 80 Kg or not more than 20% of normal weight
- American Society of Anesthesiologists (ASA) grade I or II
- No obstacles in thinking or language communication
- No epidural puncture contraindications such as disturbances of blood coagulation,
local infection of the puncture site or use of anticoagulants
Exclusion Criteria:
- Chronic obstructive pulmonary diseases
- Serious heart, liver, renal and metabolic diseases
- Cerebral thrombosis and sequela
- Serious dehydration and electrolyte imbalance
- Neuromuscular diseases
- Pregnant or parturient women
- Abnormal liver and kidney function
Locations and Contacts
Additional Information
Related publications: FOLDES FF, McNALL PG. 2-Chloroprocaine: a new local anesthetic agent. Anesthesiology. 1952 May;13(3):287-96. Steinemann TL, Sheikholeslami RR, Klein EF, Prokopius MJ. Short-acting peribulbar anesthesia with 2-chloroprocaine. J Cataract Refract Surg. 2002 Jan;28(1):195-6. Hadzic A, Arliss J, Kerimoglu B, Karaca PE, Yufa M, Claudio RE, Vloka JD, Rosenquist R, Santos AC, Thys DM. A comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004 Jul;101(1):127-32. Liu SS, Ware PD, Rajendran S. Effects of concentration and volume of 2-chloroprocaine on epidural anesthesia in volunteers. Anesthesiology. 1997 Jun;86(6):1288-93; discussion 7A. Sell A, Tein T, Pitkänen M. Spinal 2-chloroprocaine: effective dose for ambulatory surgery. Acta Anaesthesiol Scand. 2008 May;52(5):695-9. doi: 10.1111/j.1399-6576.2008.01639.x. Retraction in: Acta Anaesthesiol Scand. 2012 May;56(5):667.
Starting date: January 2008
Last updated: November 10, 2014
|